ClinicalTrials.gg
Sign In

Drug

ARQ531 clinical trials

Also written Nemtabrutinib, MK-1026 and ARQ 531.

studies test it
21
open now
12
in phase 3
3
first study started
2017

Keep track of what changes. Save the ARQ531 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Bruton's Tyrosine Kinase Inhibitor ARQ 531
5
BTK Inhibitor ARQ 531
5

Development codes

MK-1026
19
ARQ 531
17

Other names

Nemtabrutinib
21

Studies by the year they started

21 studies that test it; most in 2023 (8)

Studies that test ARQ531, by start year
YearStudies
20171
20211
20221
20238
20241
20251
20268

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
10
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it.

Leukemia, Lymphocytic, Chronic, B-Cell
7
Hematologic Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
1

Who runs them

Industry 13 · Other 8

Merck Sharp & Dohme LLC (12) · City of Hope Medical Center (2) · ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Medical College of Wisconsin (1) · Jennifer Woyach (1) · Roswell Park Cancer Institute (1) · Fred Hutchinson Cancer Center (1)

Often tested with

Tested in the same studies.

Venetoclax (2) · Rituximab (2) · Obinutuzumab (1) · Pembrolizumab (1) · Lisocabtagene maraleucel (1)

Studies

Open first, then newest update. How each study uses ARQ531 is read from its arms, and is right about nine times in ten.

Testing it · 21

See all 21 studies that test ARQ531 →

Given in every arm · 4 — ARQ531 is usual care beside what is tested

Codes

What other systems call ARQ531 · ClinicalTrials.gg INT001794

  • MeSH (NLM) C000721068ARQ531One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.